CN105796630B - A kind of filial fan grass composition and its application - Google Patents
A kind of filial fan grass composition and its application Download PDFInfo
- Publication number
- CN105796630B CN105796630B CN201610183884.8A CN201610183884A CN105796630B CN 105796630 B CN105796630 B CN 105796630B CN 201610183884 A CN201610183884 A CN 201610183884A CN 105796630 B CN105796630 B CN 105796630B
- Authority
- CN
- China
- Prior art keywords
- sup
- group
- rats
- chrysanthemum
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 244000025254 Cannabis sativa Species 0.000 title description 19
- 206010039073 rheumatoid arthritis Diseases 0.000 claims abstract description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 94
- 239000000284 extract Substances 0.000 claims description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 43
- 238000003810 ethyl acetate extraction Methods 0.000 claims description 29
- 239000003814 drug Substances 0.000 claims description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 18
- 239000003208 petroleum Substances 0.000 claims description 11
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000002024 ethyl acetate extract Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 240000006851 Duhaldea cappa Species 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 241000132446 Inula Species 0.000 claims description 4
- 238000002791 soaking Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 3
- 241000209437 Cabomba Species 0.000 claims 3
- 230000000694 effects Effects 0.000 abstract description 74
- 235000007516 Chrysanthemum Nutrition 0.000 abstract description 59
- 238000002360 preparation method Methods 0.000 abstract description 13
- 230000003356 anti-rheumatic effect Effects 0.000 abstract description 7
- 244000124209 Crocus sativus Species 0.000 abstract description 3
- 235000015655 Crocus sativus Nutrition 0.000 abstract description 3
- 235000013974 saffron Nutrition 0.000 abstract description 3
- 239000004248 saffron Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 241000723353 Chrysanthemum Species 0.000 abstract 4
- -1 n Species 0.000 abstract 1
- 241000700159 Rattus Species 0.000 description 152
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 103
- 206010042674 Swelling Diseases 0.000 description 82
- 230000008961 swelling Effects 0.000 description 82
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 80
- 238000000605 extraction Methods 0.000 description 79
- 210000003371 toe Anatomy 0.000 description 57
- 241000699670 Mus sp. Species 0.000 description 43
- 238000002474 experimental method Methods 0.000 description 37
- 206010061218 Inflammation Diseases 0.000 description 33
- 230000037396 body weight Effects 0.000 description 33
- 230000004054 inflammatory process Effects 0.000 description 33
- 244000250129 Trigonella foenum graecum Species 0.000 description 26
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 26
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 26
- 210000002683 foot Anatomy 0.000 description 25
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 24
- 206010003246 arthritis Diseases 0.000 description 22
- 235000019786 weight gain Nutrition 0.000 description 21
- 229940079593 drug Drugs 0.000 description 19
- 210000001541 thymus gland Anatomy 0.000 description 19
- 230000004584 weight gain Effects 0.000 description 19
- 241000699666 Mus <mouse, genus> Species 0.000 description 18
- 238000000034 method Methods 0.000 description 16
- 210000000056 organ Anatomy 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 15
- 208000000114 Pain Threshold Diseases 0.000 description 14
- 230000005764 inhibitory process Effects 0.000 description 14
- 230000037040 pain threshold Effects 0.000 description 14
- 210000000952 spleen Anatomy 0.000 description 14
- 210000003414 extremity Anatomy 0.000 description 12
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 11
- 230000001154 acute effect Effects 0.000 description 11
- 210000000544 articulatio talocruralis Anatomy 0.000 description 11
- 239000008096 xylene Substances 0.000 description 11
- 230000002401 inhibitory effect Effects 0.000 description 10
- 230000004044 response Effects 0.000 description 10
- 206010014025 Ear swelling Diseases 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical group [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 208000025865 Ulcer Diseases 0.000 description 8
- 238000011552 rat model Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000000638 solvent extraction Methods 0.000 description 8
- 230000036269 ulceration Effects 0.000 description 8
- 239000002671 adjuvant Substances 0.000 description 7
- 210000000548 hind-foot Anatomy 0.000 description 7
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 6
- 102000002322 Egg Proteins Human genes 0.000 description 6
- 108010000912 Egg Proteins Proteins 0.000 description 6
- 240000003109 Persicaria chinensis Species 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- 235000014103 egg white Nutrition 0.000 description 6
- 210000000969 egg white Anatomy 0.000 description 6
- 210000004969 inflammatory cell Anatomy 0.000 description 6
- 208000018937 joint inflammation Diseases 0.000 description 6
- 230000003902 lesion Effects 0.000 description 6
- 210000005222 synovial tissue Anatomy 0.000 description 6
- 240000006927 Foeniculum vulgare Species 0.000 description 5
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 5
- 239000012675 alcoholic extract Substances 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 206010020718 hyperplasia Diseases 0.000 description 5
- 210000001503 joint Anatomy 0.000 description 5
- 230000001575 pathological effect Effects 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 4
- 210000004100 adrenal gland Anatomy 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000004856 capillary permeability Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 210000005069 ears Anatomy 0.000 description 4
- 230000037406 food intake Effects 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 230000035699 permeability Effects 0.000 description 4
- 210000001258 synovial membrane Anatomy 0.000 description 4
- 208000006379 syphilis Diseases 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical group CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 3
- 206010003694 Atrophy Diseases 0.000 description 3
- 244000133098 Echinacea angustifolia Species 0.000 description 3
- 206010023232 Joint swelling Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- 230000001760 anti-analgesic effect Effects 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 230000037444 atrophy Effects 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 210000004744 fore-foot Anatomy 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 210000003141 lower extremity Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000006996 mental state Effects 0.000 description 3
- 235000021590 normal diet Nutrition 0.000 description 3
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010006002 Bone pain Diseases 0.000 description 2
- 241000963441 Calystegia soldanella Species 0.000 description 2
- 241000207782 Convolvulaceae Species 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 208000009386 Experimental Arthritis Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 240000001307 Myosotis scorpioides Species 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical group CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 241000545405 Tripterygium Species 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 235000002020 sage Nutrition 0.000 description 2
- 210000002437 synoviocyte Anatomy 0.000 description 2
- 201000004595 synovitis Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 241000217444 Calystegia Species 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000234642 Festuca Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000830536 Tripterygium wilfordii Species 0.000 description 1
- 240000002383 Vandopsis gigantea Species 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000037308 hair color Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000010172 mouse model Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 208000030428 polyarticular arthritis Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000015398 thunder god vine Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及一种孝扇草羊耳菊组合物及其应用,所述孝扇草羊耳菊组合物,由质量之比为1~5:1的孝扇草和羊耳菊组成。本发明所述的孝扇草羊耳菊组合物在制备抗类风湿性关节炎的应用的有益效果如下:本发明组合物可有效治疗类风湿性关节炎,效果优于单独使用孝扇草,具有很好的临床应用前景。
The present invention relates to a composition of saffron chrysanthemum and an application thereof. The composition of chrysanthemum chrysanthemum consists of chrysanthemum and chrysanthemum with a mass ratio of 1 to 5:1. The beneficial effect of the application of the Filibulum chinensis composition of the present invention in the preparation of anti-rheumatoid arthritis is as follows: the composition of the present invention can effectively treat rheumatoid arthritis, and the effect is better than that of using Filiaria fructus alone, It has a good clinical application prospect.
Description
(一)技术领域(1) Technical field
本发明涉及一种孝扇草羊耳菊组合物及其应用。The present invention relates to a composition and application thereof.
(二)背景技术(2) Background technology
类风湿性关节炎是一种以骨关节滑膜炎为特征的,以对称性多关节炎为主要临床表现的异质性、系统性、慢性自身免疫功能障碍疾病。全世界发病率为1%,我国发病率为0.3%,发病一年内致残率高达20%,严重影响人类的健康和生活质量。目前临床用于治疗类风湿性关节炎的药物都存在毒性和耐受性的矛盾,新型的一些生物制剂由于价格昂贵应用受限。Rheumatoid arthritis is a heterogeneous, systemic, chronic autoimmune dysfunction disease characterized by osteoarticular synovitis and symmetric polyarthritis as the main clinical manifestation. The incidence rate is 1% in the world, 0.3% in my country, and the disability rate is as high as 20% within one year of the onset, seriously affecting human health and quality of life. At present, the drugs used clinically to treat rheumatoid arthritis all have contradictions in toxicity and tolerance, and some new biological agents are limited in application due to their high price.
孝扇草为旋花科(Convolvulaceae)打碗花属(Calystegia)植物肾叶打碗花(Calystegia soldanella(L.)R.Br.[Convolvulus soldanella L.]),民间多以全草及根状茎入药。其资源丰富,药用历史悠久,主要有祛风利湿,化痰止咳,清肺止血,利尿解毒等功效。用于治疗咳嗽,肾炎水肿,风湿关节疼痛,痹症等。Filial fan grass is Calystegia soldanella (L.) R.Br. [Convolvulus soldanella L.]), a plant of the genus Calystegia in the Convolvulaceae family (Convolvulaceae). The stem is used as medicine. It is rich in resources and has a long history of medicinal use. It mainly has the functions of dispelling wind and dampness, resolving phlegm and relieving cough, clearing lung and stopping bleeding, diuresis and detoxification. For the treatment of cough, nephritis edema, rheumatic joint pain, arthralgia and so on.
羊耳菊(Inula cappa(Buch.-Ham.)DC.)为菊科(Compositae)旋覆花属植物,药味苦微辛,性平无毒,以全草或根花入药,收载于《中国壮药学》及《中国民族药炮制集成》,具有行气止痛、祛风消肿之功,主治风湿骨痛、跌打损伤、感冒风寒等。在我国广西、云南、贵州等省的侗、傣、景颇、拉祜、傈僳、苗、彝、佤、壮等族的民间作为多种风湿骨痛方剂中主药运用,有丰富的药用经验。近年来对羊耳菊研究药理活性的报道较少,目前仅发现有抗氧化作用和抑菌作用。Inula cappa (Buch.-Ham.) DC. is a plant of the genus Inula in the family Compositae. "Chinese Zhuang Pharmacy" and "Chinese Ethnic Medicine Processing Integration", have the functions of promoting qi and relieving pain, dispelling wind and reducing swelling, and mainly treating rheumatic bone pain, bruises, colds and colds, etc. In Guangxi, Yunnan, Guizhou and other provinces of my country, the people of the Dong, Dai, Jingpo, Lahu, Lisu, Miao, Yi, Wa, Zhuang and other ethnic groups have used it as the main drug in a variety of rheumatism and bone pain prescriptions, and have rich medicinal experience. In recent years, there have been few reports on the study of pharmacological activity of Fructus Fructus, and only anti-oxidation and antibacterial effects have been found so far.
(三)发明内容(3) Contents of the invention
本发明目的是提供一种孝扇草羊耳菊组合物及其在制备抗类风湿性关节炎药物中的应用。The object of the present invention is to provide a composition of fenugreek chrysanthemum and its application in the preparation of anti-rheumatoid arthritis drugs.
本发明采用的技术方案是:The technical scheme adopted in the present invention is:
一种孝扇草羊耳菊组合物,由质量之比为1~5:1的孝扇草和羊耳菊组成。A composition of chrysanthemum chrysanthemum and chrysanthemum chrysanthemum in mass ratio of 1-5:1.
所述孝扇草和羊耳菊质量之比优选为2:1。The mass ratio of the filial leaf grass and the chrysanthemum chrysanthemum is preferably 2:1.
本发明还涉及孝扇草羊耳菊组合物在制备治疗类风湿性关节炎的药物中的应用。The present invention also relates to the application of the composition of fenugreek chrysanthemum in the preparation of medicine for treating rheumatoid arthritis.
具体的,所述孝扇草羊耳菊提取物在制备治疗类风湿性关节炎的药物中的应用,所述提取物为水提取物、醇提取物或醇提乙酸乙酯萃取部位。Concretely, the application of the extract of Filiaria fragrans Fructus Chrysanthemi in the preparation of medicine for treating rheumatoid arthritis, the extract is water extract, alcohol extract or alcohol extraction ethyl acetate extraction part.
水提物制备方法:取孝扇草羊耳菊组合物干燥粗粉,孝扇草与羊耳菊粗粉质量比为1~5:1,加入药材8~10倍量的水,提取前浸泡1~2h,加热回流提取2~3次,每次1~2h,减压抽滤后浓缩,即得。The preparation method of the water extract: take the dry coarse powder of the composition of the chrysanthemum chrysanthemum and the chrysanthemum chrysanthemum, the mass ratio of the chrysanthemum and the chrysanthemum powder is 1-5:1, add 8-10 times the amount of water of the medicinal material, and soak before extraction 1 to 2 hours, heated and refluxed for 2 to 3 times, each time for 1 to 2 hours, concentrated under reduced pressure and then obtained.
醇提物制备方法:取孝扇草羊耳菊组合物干燥粗粉,孝扇草与羊耳菊粗粉质量比为1~5:1,加入药材8~10倍量的50%乙醇,提取前浸泡30min~2h,加热回流提取2~3次,每次1~2h,减压抽滤后浓缩,即得。The preparation method of the alcohol extract: take the dry coarse powder of the composition of Fructus chinensis and Fructus chinensis, the mass ratio of Fenium persicae and Fructus chinensis coarse powder is 1-5:1, add 50% ethanol of 8-10 times the amount of medicinal materials, extract Pre-soak for 30min-2h, extract by heating and reflux for 2-3 times, each time for 1-2h, concentrate under reduced pressure and suction to obtain the product.
经试验比较发现,孝扇草羊耳菊乙酸乙酯提取物效果最佳,因此,所述提取物优选为孝扇草羊耳菊乙酸乙酯提取物,由如下方法制备得到:取其孝扇草与羊耳菊干燥粗粉,孝扇草与羊耳菊粗粉质量比为1~5:1,加入10~12倍量80~95%乙醇,浸泡1~2h后加热回流提取2~3次,每次1~2h,合并两次滤液,回收乙醇,浓缩至无醇味,加适量水溶解,先用石油醚萃取至无色,萃余溶液再用乙酸乙酯萃取至无色,取乙酸乙酯萃取部位,挥干溶剂,即得孝扇草羊耳菊乙酸乙酯提取物。Through test comparison, it is found that the ethyl acetate extract of Fenugreek fruticosa has the best effect, therefore, the extract is preferably the ethyl acetate extract of Filium fructus Fructus Fructus, which is prepared by the following method: take its Dried grass and sheep ear chrysanthemum powder, the mass ratio of fennel grass and sheep ear chrysanthemum powder is 1 to 5:1, add 10 to 12 times the amount of 80 to 95% ethanol, soak for 1 to 2 hours, then heat and reflux to extract 2 to 3 once, 1-2 hours each time, combine the two filtrates, recover ethanol, concentrate until there is no alcohol smell, add appropriate amount of water to dissolve, first extract with petroleum ether until colorless, then extract the raffinate solution with ethyl acetate until colorless, take Ethyl acetate extraction part, the solvent is evaporated to get the ethyl acetate extract of Fenugreek chrysanthemum.
所述药物可添加合适的药用辅料,制成下列之一的剂型:①注射液,②片剂,③胶囊剂,④颗粒剂,⑤汤剂。The medicine can be prepared into one of the following dosage forms by adding suitable pharmaceutical excipients: ① injection, ② tablet, ③ capsule, ④ granule, ⑤ decoction.
本发明以其活性为先导,对孝扇草羊耳菊组合物抗炎镇痛、抗风湿和抗类风湿性关节炎的有效部位进行研究,实验从不同提取物及萃取部位着手,选用经典的小鼠热板法、扭体法、二甲苯致小鼠耳廓肿胀法等抗炎镇痛模型和佐剂性关节炎大鼠模型,在整体水平上进行抗炎镇痛、抗风湿和抗类风湿性关节炎药效学研究,探讨了孝扇草羊耳菊组合物对抗炎镇痛模型小鼠的影响,对佐剂性关节炎大鼠模型的足趾肿胀度、关节炎指数和脏器指数的影响,初步确定孝扇草羊耳菊组合物最佳有效部位为孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位。The present invention takes its activity as the forerunner to study the effective part of anti-inflammatory, analgesic, anti-rheumatism and anti-rheumatoid arthritis of the composition of Filiaria sativa, anti-rheumatism and anti-rheumatoid arthritis. The experiment starts with different extracts and extraction parts, and selects the classic Anti-inflammatory and analgesic models such as mouse hot plate method, writhing method, xylene-induced mouse ear swelling method and adjuvant arthritis rat model, anti-inflammatory and analgesic, anti-rheumatic and anti-rheumatoid at the overall level Pharmacodynamics study of acute arthritis, explored the effects of the composition of filial genus Fructus chrysanthemum on anti-inflammatory and analgesic model mice, and on the toe swelling degree, arthritis index and viscera of adjuvant arthritis rat model Influenced by the index, it is preliminarily determined that the best effective part of the composition of Fenugreek Fructus is the ethyl acetate extraction part of the composition of Fenugreek Fructus.
本发明所述的孝扇草羊耳菊组合物在制备抗类风湿性关节炎的应用的有益效果如下:本发明组合物可有效治疗类风湿性关节炎,效果优于孝扇草单方,具有很好的临床应用前景。The beneficial effect of the application of the composition of Filiaria fragrans Fructus in the present invention in the preparation of anti-rheumatoid arthritis is as follows: the composition of the present invention can effectively treat rheumatoid arthritis, and the effect is better than that of Filiaria fragrans alone, and has Very good prospects for clinical application.
(四)附图说明(4) Description of drawings
图1为大鼠滑膜组织图(10×10),A:空白;B:模型;C:阳性;D:给药;Fig. 1 is a rat synovial tissue diagram (10×10), A: blank; B: model; C: positive; D: administration;
图2为大鼠滑膜组织图(10×20),A:空白;B:模型;C:阳性;D:给药。Fig. 2 is a histological diagram of rat synovium (10×20), A: blank; B: model; C: positive; D: administration.
(五)具体实施方式(5) Specific implementation methods
下面结合具体实施例对本发明进行进一步描述,但本发明的保护范围并不仅限于此:The present invention is further described below in conjunction with specific embodiment, but protection scope of the present invention is not limited thereto:
实施例1:Example 1:
孝扇草羊耳菊水提取物制备:取孝扇草羊耳菊组合物干燥粗粉,孝扇草与羊耳菊粗粉质量比为2:1,加入药材8倍质量的水,浸泡1h后,加热回流提取2次,每次1h,减压抽滤后浓缩至相对密度为1.10,即得。The preparation of the water extract of the chrysanthemum chrysanthemum: take the dry coarse powder of the chrysanthemum chrysanthemum composition, the mass ratio of the chrysanthemum chrysanthemum and the chrysanthemum powder is 2:1, add water with 8 times the mass of the medicinal material, and soak for 1 hour , heated and refluxed for 2 extractions, 1 hour each time, vacuum filtered and then concentrated to a relative density of 1.10.
孝扇草羊耳菊醇提物制备:取孝扇草羊耳菊组合物干燥粗粉,孝扇草与羊耳菊粗粉质量比为2:1,加入药材10倍质量的50%(v/v)乙醇,浸泡30min后,加热回流提取2次,每次1h,减压抽滤后浓缩至相对密度为1.10,即得。Preparation of Alcohol Extract of Echinacea Echinacea: Take the dry coarse powder of Echinacea Echinacea Composition, the mass ratio of Echinacea Echinacea to coarse powder is 2:1, add 50% (v /v) ethanol, after soaking for 30 minutes, heating and refluxing to extract twice, each time for 1 hour, and concentrating to a relative density of 1.10 after vacuum filtration, to obtain the final product.
孝扇草羊耳菊乙酸乙酯萃取部位(即乙酸乙酯提取物)制备:取孝扇草羊耳菊组合物干燥粗粉,孝扇草与羊耳菊粗粉质量比为2:1,加入10倍质量的95%乙醇,浸泡1h后加热回流提取2次,每次2h,合并两次滤液,滤过,回收乙醇,浓缩至无醇味,加少量水溶解,先用石油醚萃取,萃余溶液再用乙酸乙酯萃取至无色,取乙酸乙酯萃取部位挥干溶剂,即得孝扇草羊耳菊乙酸乙酯萃取部位。Preparation of the ethyl acetate extraction part (i.e., ethyl acetate extract) of P. chinensis: Take the dry coarse powder of the composition of P. chinensis, and the mass ratio of P. chinensis and P. chinensis coarse powder is 2:1, Add 10 times the mass of 95% ethanol, soak for 1 hour, heat and reflux for extraction twice, each time for 2 hours, combine the two filtrates, filter, recover ethanol, concentrate until no alcohol smell, add a small amount of water to dissolve, first extract with petroleum ether, The raffinate solution was then extracted with ethyl acetate until it was colorless, and the ethyl acetate extraction part was evaporated to dry the solvent to obtain the ethyl acetate extraction part of Saffron chrysanthemum.
孝扇草羊耳菊石油醚萃取部位制备:取孝扇草羊耳菊组合物干燥粗粉,孝扇草与羊耳菊粗粉质量比为2:1,加入10倍质量的95%乙醇,浸泡1h后加热回流提取2次,每次2h,合并两次滤液,滤过,回收乙醇,浓缩至无醇味,加少量水溶解,再用石油醚萃取至无色,取石油醚萃取部位挥干溶剂,即得孝扇草羊耳菊石油醚萃取部位。Preparation of the petroleum ether extraction part of P. chinensis: Take the dry coarse powder of the composition of P. chinensis and S. chrysanthemum powder at a mass ratio of 2:1, add 10 times the mass of 95% ethanol, After soaking for 1 hour, heat and reflux to extract twice, each time for 2 hours, combine the two filtrates, filter, recover ethanol, concentrate until there is no alcohol smell, add a small amount of water to dissolve, then extract with petroleum ether until it is colorless, take the petroleum ether extraction part and volatilize Dry the solvent to obtain the petroleum ether extraction part of the filial sage chrysanthemum.
孝扇草羊耳菊正丁醇萃取部位及剩余部位制备:取孝扇草羊耳菊组合物干燥粗粉,孝扇草与羊耳菊粗粉质量比为2:1,加入10倍质量的95%乙醇,浸泡1h后加热回流提取2次,每次2h,合并两次滤液,滤过,回收乙醇,浓缩至无醇味,加少量水溶解,先用石油醚萃取,所得萃余溶液用乙酸乙酯萃取,所得萃余溶液再用正丁醇萃取至无色,取正丁醇萃取部位挥干溶剂,即得孝扇草羊耳菊正丁醇萃取部位,并得到溶剂萃取后剩余部位(即正丁醇萃余溶液)备用。The preparation of the n-butanol extraction part and the remaining parts of the genus chrysanthemum chrysanthemum: take the dry coarse powder of the chrysanthemum chrysanthemum composition, the mass ratio of the chrysanthemum chrysanthemum and the chrysanthemum chrysanthemum powder is 2:1, and add 10 times the mass of 95% ethanol, after soaking for 1 hour, heat and reflux to extract twice, each time for 2 hours, combine the two filtrates, filter, recover ethanol, concentrate until there is no alcohol smell, add a small amount of water to dissolve, first extract with petroleum ether, and use the raffinate solution obtained Ethyl acetate extraction, and the obtained raffinate solution was extracted with n-butanol until it was colorless, and the n-butanol extraction part was evaporated to dry the solvent to obtain the n-butanol extraction part of Fenugreek chrysanthemum, and the remaining part after solvent extraction (i.e. n-butanol raffinate solution) for subsequent use.
实验方法1:Experimental method 1:
小鼠热板法实验:雄性ICR小鼠50只,体重(20±2)g(剔除过敏感及不敏感动物),随机分为5组,每组10只,即为空白对照组,孝扇草羊耳菊组合物水提物低、中、高剂量组(分别为生药量2.5g·kg-1、5.0g·kg-1、10.0g·kg-1),阳性药(阿司匹林)组(0.25g·kg-1)。药物均调节至相应浓度按0.2ml·10g-1灌胃给药,每天一次,空白对照组给同体积蒸馏水,连续7d,末次给药1h后,将小鼠放在55℃金属板上,以小鼠舔后足或跳跃反应潜伏期为痛阈指标,记录在金属板上停留的时间。Mouse hot plate experiment: 50 male ICR mice, weighing (20±2) g (excluding hypersensitive and insensitive animals), were randomly divided into 5 groups with 10 mice in each group, which was the blank control group. The low, medium and high dose groups (respectively, crude drug amounts of 2.5g·kg -1 , 5.0g·kg -1 , 10.0g·kg -1 ) of the aqueous extract of the composition of Sheepearm chinensis, the positive drug (aspirin) group ( 0.25g·kg -1 ). All the drugs were adjusted to the corresponding concentration and administered by intragastric administration at 0.2ml·10g -1 once a day. The blank control group was given the same volume of distilled water for 7 consecutive days. One hour after the last administration, the mice were placed on a metal plate at 55°C to The latency of the mouse licking the hind paw or jumping response was used as the pain threshold index, and the time spent on the metal plate was recorded.
实验结果:Experimental results:
对小鼠痛阈值的影响:结果表明孝扇草羊耳菊组合物水提物各剂量组能提高小鼠的痛阈值,与空白对照组相比有非常显著差异(P<0.001),提示孝扇草羊耳菊组合物水提物组有非常显著的镇痛作用。见表1。Effects on the pain threshold of mice: the results showed that each dose group of the water extract of the filial genus Fructus chrysanthemum composition can improve the pain threshold of the mice, and there was a very significant difference (P<0.001) compared with the blank control group, suggesting that filial piety The water extract group of the composition of scalloped chrysanthemum has a very significant analgesic effect. See Table 1.
表1:孝扇草羊耳菊组合物水提物对小鼠痛阈值的影响(n=10)Table 1: Effects of the water extract of the filial scallop grass composition water extract on the pain threshold of mice ( n=10)
注:与空白对照组比较,**P<0.001。Note: Compared with blank control group, ** P<0.001.
实验方法2:Experimental method 2:
小鼠醋酸扭体法实验:雄性ICR小鼠50只,体重(20±2)g,分组与给药方法同实验方法1,连续7d,末次给药后1h后,各小鼠腹腔注射0.6%的乙酸0.1ml·10g-1,观察15min内由乙酸引起的扭体次数,并计算抑制率。抑制率(%)=(生理盐水组扭体次数-试药组扭体次数)/生理盐水组扭体次数×100%。Mouse acetic acid writhing experiment: 50 male ICR mice, weighing (20±2) g, grouped and administered as in Experiment 1, for 7 consecutive days, and 1 hour after the last administration, each mouse was intraperitoneally injected with 0.6% acetic acid 0.1ml·10g -1 , observe the number of writhing caused by acetic acid within 15min, and calculate the inhibition rate. Inhibition rate (%) = (writhing times in the normal saline group - writhing times in the test drug group)/writhing times in the normal saline group × 100%.
实验结果:Experimental results:
对醋酸所致小鼠扭体反应的影响:结果见表2。结果所示,孝扇草羊耳菊组合物水提物各剂量组均能明显减少醋酸所致小鼠扭体反应次数,与空白组比较有非常显著的差异(P<0.001)。表明孝扇草羊耳菊组合物水提物具有非常显著的镇痛作用。Effects on the writhing response of mice induced by acetic acid: the results are shown in Table 2. The results showed that each dose group of the water extract of the chrysanthemum chrysanthemum composition can significantly reduce the number of writhing reactions in mice caused by acetic acid, and there is a very significant difference compared with the blank group (P<0.001). It shows that the water extract of the composition of Filiaria sativa has a very significant analgesic effect.
表2:孝扇草羊耳菊组合物水提物对乙酸所致小鼠扭体反应的影响(n=10)Table 2: Effects of the aqueous extract of the filial scalloped grass chrysanthemum composition on the writhing response of mice induced by acetic acid ( n=10)
注:与空白对照组比较,**P<0.001。Note: Compared with blank control group, ** P<0.001.
实验方法3:Experimental method 3:
拮抗二甲苯致小鼠耳肿胀实验:雄性ICR小鼠50只,体重(20±2)g,分组与给药方法同实验方法1,末次给药1h后,于小鼠右耳前后涂二甲苯0.02ml/只,左耳不做任何处理。4h后将动物断椎处死,剪下双耳,用9mm直径打孔器分别在同一部位打下圆耳片,电子天平称重,每鼠右耳重量减去左耳重量为肿胀度。肿胀抑制率=(对照组平均肿胀度-给药组平均肿胀度)/对照组平均肿胀度×100%。Antagonism xylene-induced mouse ear swelling experiment: 50 male ICR mice, weighing (20±2) g, grouped and administered as in Experiment 1, 1 hour after the last administration, apply xylene on the front and back of the right ear of the mice 0.02ml/piece, the left ear is left untreated. After 4 hours, the animal was sacrificed by broken vertebrae, both ears were cut off, and round ears were punched in the same position with a 9mm diameter punch, and weighed with an electronic balance. The weight of the right ear of each mouse minus the weight of the left ear was the degree of swelling. Swelling inhibition rate=(average swelling degree of control group-average swelling degree of drug-administered group)/average swelling degree of control group×100%.
实验结果:Experimental results:
对二甲苯所致小鼠耳廓肿胀的影响:结果见表3。结果所示,孝扇草羊耳菊组合物水提物各剂量组对二甲苯致小鼠耳廓肿胀有非常显著的抑制作用。Effect of xylene-induced ear swelling in mice: the results are shown in Table 3. The results showed that each dosage group of the water extract of the composition of Filiaria sativa has a very significant inhibitory effect on the swelling of the mouse auricle induced by xylene.
表3:孝扇草羊耳菊组合物水提物对二甲苯所致小鼠耳廓肿胀的影响(n=10)Table 3: The effect of the water extract of the composition of filial fan grass Fructus chrysanthemum on the swelling of the mouse auricle caused by xylene ( n=10)
注:与空白对照组比较,**P<0.001。Note: Compared with blank control group, ** P<0.001.
实验方法4:Experimental method 4:
小鼠毛细血管通透性实验:雄性ICR小鼠50只,体重(20±2)g,分组与给药方法同实验方法1,连续7d,末次给药后1h,分别给小鼠尾静脉注射0.5%伊文思蓝生理盐水溶液0.1ml·10g-1,随即腹腔注射0.6%醋酸生理盐水溶液0.1ml·10g-1,20min后处死,剪开腹部皮肤肌肉,用6ml生理盐水洗涤腹腔,吸出洗涤液,加生理盐水至10ml,3000r·min-1离心10min,取上清液于576nm处测定其吸收值。以空白对照组小鼠染料渗出量为100%计算给药小鼠腹腔渗出的抑制率。以抑制率值计算通透性。Capillary permeability experiment in mice: 50 male ICR mice, body weight (20±2) g, the grouping and administration method were the same as the experimental method 1, for 7 consecutive days, and 1 hour after the last administration, the mice were injected into the tail vein respectively 0.5% Evans blue normal saline solution 0.1ml·10g -1 , then intraperitoneally injected 0.6% acetic acid normal saline solution 0.1ml·10g -1 , put to death 20 minutes later, cut off the abdominal skin and muscles, washed the abdominal cavity with 6ml normal saline, sucked out and washed solution, add physiological saline to 10ml, centrifuge at 3000r·min -1 for 10min, take the supernatant and measure its absorbance at 576nm. The inhibition rate of the peritoneal exudation of the administered mice was calculated by taking the dye exudation amount of the mice in the blank control group as 100%. Permeability was calculated as inhibition rate value.
抑制率=(空白对照组渗出量-用药组渗出量)/空白对照组渗出量×100%。Inhibition rate=(blank control group exudation amount-medication group exudation amount)/blank control group exudation amount×100%.
实验结果:Experimental results:
对小鼠毛细血管通透性的影响:结果见表4。结果所示,与空白组比较,孝扇草羊耳菊组合物水提物各剂量组均可降低由醋酸引起的小鼠毛细血管通透性的增加,腹腔毛细血管渗透液的吸光值显著降低(P<0.001),即对急性炎症渗出有明显的抑制作用。Effect on capillary permeability in mice: the results are shown in Table 4. The results show that, compared with the blank group, each dose group of the water extract of the chrysanthemum chrysanthemum composition can reduce the increase of the capillary permeability of mice caused by acetic acid, and the absorbance value of the peritoneal capillary permeate is significantly reduced. (P<0.001), that is, it has obvious inhibitory effect on acute inflammatory exudation.
表4:孝扇草羊耳菊组合物水提物对小鼠毛细血管通透性的影响(n=10)Table 4: Effects of the water extract of the composition of filial fan grass Fructus chrysanthemum on the permeability of capillaries in mice ( n=10)
注:与空白对照组比较,**P<0.001。Note: Compared with blank control group, ** P<0.001.
实验方法5:Experimental method 5:
拮抗鸡蛋清致小鼠足肿胀实验:昆明种小鼠50只,体重(20±2)g,分组与给药方法同实验方法1,连续7d。末次给药60min后,测定各小鼠的右后足趾容积,各小鼠右后足趾皮下注射0.1ml鸡蛋清(室温24℃),于注射后1h、3h、6h分别测定各鼠右后足趾容积,比较各组小鼠药后不同时间右后足趾肿胀率。按下式计算:肿胀率(%)=(致炎后足趾容积值-致炎前足趾容积值)/致炎前足趾容积值×100%,肿胀抑制率(%)=(对照组平均肿胀率-给药组平均肿胀率)/对照组平均肿胀率×100%。Antagonism experiment of egg white-induced mouse paw swelling: 50 Kunming mice, weighing (20±2) g, grouped and administered in the same way as experimental method 1, for 7 consecutive days. 60 minutes after the last administration, the volume of the right hind toe of each mouse was measured, each mouse was subcutaneously injected with 0.1ml of egg white (room temperature 24°C), and the volume of the right hind toe of each mouse was measured 1h, 3h, and 6h after the injection. Toe volume, the swelling rate of the right hind toe of mice in each group at different times after drug treatment was compared. Calculate according to the following formula: swelling rate (%) = (volume value of toe after inflammation - volume value of toe before inflammation) / volume value of toe before inflammation × 100%, swelling inhibition rate (%) = (average swelling of the control group rate - the average swelling rate of the treatment group) / the average swelling rate of the control group × 100%.
实验结果:Experimental results:
对鸡蛋清致小鼠足肿胀的影响:结果见表5。结果表明,鸡蛋清诱发小鼠足水肿的急性非感染性炎症模型,肿胀高峰在致炎后2h。从表5可见,孝扇草羊耳菊组合物水提物各剂量组对鸡蛋清致小鼠足肿胀有非常显著的抑制作用(P<0.001)。Effect on mouse paw swelling caused by egg white: see Table 5 for the results. The results showed that in the acute non-infectious inflammation model of mouse foot edema induced by egg white, the swelling peak was 2 hours after the inflammation. It can be seen from Table 5 that each dosage group of the water extract of the composition of F. miltiorrhiza chrysanthemum has a very significant inhibitory effect on mouse paw swelling induced by egg white (P<0.001).
表5:孝扇草羊耳菊组合物水提物对鸡蛋清致小鼠足肿胀的影响(n=10)Table 5: The effect of the water extract of the composition of filial fan grass chrysanthemum chrysanthemum on egg white-induced mouse paw swelling ( n=10)
注:与空白对照组比较,**P<0.001。Note: Compared with blank control group, ** P<0.001.
实施例2:Example 2:
实验方法1:随机分为5组,每组10只,即为空白对照组,孝扇草羊耳菊组合物醇提物低、中、高剂量组(分别为生药量2.5g·kg-1、5.0g·kg-1、10.0g·kg-1),阳性药(阿司匹林)组(0.25g·kg-1)。其余方法同实施例1。Experimental method 1: randomly divided into 5 groups, 10 in each group, namely the blank control group, low, medium and high dose groups (respectively crude drug amount 2.5g kg -1 , 5.0g·kg -1 , 10.0g·kg -1 ), positive drug (aspirin) group (0.25g·kg -1 ). All the other methods are the same as in Example 1.
实验结果:Experimental results:
对小鼠痛阈值的影响:结果表明孝扇草羊耳菊组合物醇提物各剂量组可明显提高热致痛小鼠的痛阈值,与空白组比较具非常显著差异(P<0.001),其痛阈值提高率略高于阿司匹林。提示孝扇草羊耳菊组合物醇提物组有非常显著的镇痛作用。见表6。Effects on the pain threshold of mice: the results showed that each dose group of the alcohol extract of the composition of Filiaria sativa can significantly improve the pain threshold of heat-induced pain mice, which is very significantly different from that of the blank group (P<0.001), Its pain threshold increase rate is slightly higher than that of aspirin. It is suggested that the alcohol extract group of the composition of Fenugreek chrysanthemum has a very significant analgesic effect. See Table 6.
表6:孝扇草羊耳菊组合物醇提物对小鼠痛阈值的影响(n=10)Table 6: Effects of the alcoholic extract of the composition of filial leaf grass Fructus chrysanthemum on the pain threshold of mice ( n=10)
注:与空白对照组比较,**P<0.001。Note: Compared with blank control group, ** P<0.001.
实验方法2:方法同实施例1,只是给药换为孝扇草羊耳菊组合物醇提物。Experimental method 2: The method is the same as that in Example 1, except that the administration is replaced by the alcohol extract of the composition of Fenugreek chrysanthemum.
实验结果:Experimental results:
对醋酸所致小鼠扭体反应的影响:结果见表7。结果所示,孝扇草羊耳菊组合物醇提物各剂量组均能明显减少醋酸所致小鼠扭体反应次数,与空白组比较有极显著性差异(P<0.01,P<0.001),提示孝扇草羊耳菊醇提物各剂量组对醋酸所致小鼠扭体反应有非常明显的抑制作用,表明孝扇草羊耳菊组合物醇提物具有非常显著的镇痛作用。Effect on the writhing response of mice induced by acetic acid: the results are shown in Table 7. The results showed that each dose group of the alcohol extract of the composition of Filiaria sylvestris chrysanthemum can significantly reduce the number of writhing reactions in mice caused by acetic acid, and there is a very significant difference compared with the blank group (P<0.01, P<0.001) , suggesting that each dosage group of Alcohol extract of Fenugreek Fructus has a very obvious inhibitory effect on the writhing response of mice induced by acetic acid, indicating that the alcohol extract of Fructus Fructus Fructus composition has a very significant analgesic effect.
表7:孝扇草羊耳菊组合物醇提物对乙酸所致小鼠扭体反应的影响(n=10)Table 7: Effects of the alcoholic extract of the composition of filial leaf grass Fructus chrysanthemum on the writhing reaction of mice induced by acetic acid ( n=10)
注:与空白对照组比较,*P<0.01,**P<0.001。Note: Compared with blank control group, * P<0.01, ** P<0.001.
实验方法3:方法同实施例1,只是给药换为孝扇草羊耳菊组合物醇提物。Experimental method 3: The method is the same as that in Example 1, except that the administration is replaced by the alcohol extract of the composition of Fenugreek chrysanthemum.
实验结果:Experimental results:
对二甲苯所致小鼠耳廓肿胀的影响:结果见表8。结果所示,孝扇草羊耳菊组合物醇提物各剂量组对二甲苯致小鼠耳廓肿胀有非常显著的抑制作用。Effect of xylene-induced ear swelling in mice: the results are shown in Table 8. The results showed that each dose group of the ethanol extract of the composition of Fenugreek chrysanthemum had a very significant inhibitory effect on the swelling of the mouse auricle induced by xylene.
表8:孝扇草羊耳菊组合物醇提物对二甲苯所致小鼠耳廓肿胀的影响(n=10)Table 8: The effect of the alcohol extract of the composition of Filiaria sativa on the ear swelling of mice caused by xylene ( n=10)
注:与空白对照组比较,**P<0.001。Note: Compared with blank control group, ** P<0.001.
实验方法4:Experimental method 4:
方法同实施例1,只是给药换为孝扇草羊耳菊组合物醇提物。The method is the same as that in Example 1, except that the administration is replaced by the alcohol extract of the composition of Fenugreek chrysanthemum.
实验结果:Experimental results:
对小鼠毛细血管通透性的影响:结果见表9。结果所示,与空白组比较,孝扇草羊耳菊组合物醇提物各剂量组均可降低由醋酸引起的小鼠毛细血管通透性的增加,腹腔毛细血管渗透液的吸光值显著降低(P<0.01,P<0.001),即对急性炎症渗出有明显的抑制作用。Effects on the permeability of mouse capillaries: the results are shown in Table 9. The results show that, compared with the blank group, each dose group of the alcohol extract of the composition of Fenugreek chrysanthemum can reduce the increase of the capillary permeability of mice caused by acetic acid, and the absorbance value of the peritoneal capillary permeate fluid is significantly reduced. (P<0.01, P<0.001), that is, it has obvious inhibitory effect on acute inflammatory exudation.
表9:孝扇草羊耳菊组合物醇提物对小鼠毛细血管通透性的影响(n=10)Table 9: Effects of the alcoholic extract of the composition of filial piety fennel chrysanthemum on the permeability of capillaries in mice ( n=10)
注:与空白对照组比较,*P<0.01,**P<0.001。Note: Compared with blank control group, * P<0.01, ** P<0.001.
实施例3:Example 3:
实验方法1:方法同实施例1,只是给药换为孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位。Experimental method 1: The method is the same as that in Example 1, except that the administration is replaced by alcohol extraction of the ethyl acetate extraction part of the Fructus fruticosa composition.
实验结果:Experimental results:
对小鼠痛阈值的影响:结果表明孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(Ⅱ组)和各溶剂萃取后剩余部位组(Ⅳ组)能显著提高小鼠的痛阈值,与空白组比较有显著差异(P<0.05,P<0.01)。结果见表10。The effect on the pain threshold of mice: the results show that the group of ethyl acetate extraction parts (group Ⅱ) and the remaining parts after solvent extraction (group Ⅳ) can significantly improve the pain threshold of mice , compared with the blank group (P<0.05, P<0.01). The results are shown in Table 10.
表10孝扇草羊耳菊组合物醇提各萃取部位对小鼠痛阈值的影响(x±s,n=10)Table 10 Effects of Alcohol Extraction of Each Extraction Parts of Filiaria sativa Composition on the Pain Threshold of Mice (x±s, n=10)
注:与空白组比较,*P<0.05,**P<0.01。Note: Compared with the blank group, * P<0.05, ** P<0.01.
实验方法2:方法同实施例1,只是给药换为孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位。Experimental method 2: The method is the same as that in Example 1, except that the administration is replaced by alcohol extraction of the ethyl acetate extraction part of the Fructus fruticosa composition.
实验结果:Experimental results:
对醋酸所致小鼠扭体反应的影响:结果见表11。结果所示,孝扇草羊耳菊组合物醇提各萃取部位均能明显减少醋酸致小鼠扭体反应次数,与空白组比较具有显著性差异(P<0.05,P<0.01)。表明孝扇草羊耳菊组合物醇提各萃取部位具有显著的镇痛作用。Effects on the writhing response of mice induced by acetic acid: the results are shown in Table 11. The results showed that the alcohol extraction of each extraction part of the composition of Fenugreek chrysanthemum can significantly reduce the number of writhing reactions in mice induced by acetic acid, and there is a significant difference compared with the blank group (P<0.05, P<0.01). It shows that the alcohol extraction of each extraction part of the composition of F. miltiorrhiza has a significant analgesic effect.
表11:孝扇草羊耳菊组合物醇提各萃取部位对醋酸致小鼠扭体反应的影响(x±s,n=12)Table 11: Effects of alcohol extraction of each extraction part of the composition of Fructus chinensis chrysanthemum on the writhing response of mice induced by acetic acid (x±s, n=12)
注:与空白组比较,*P<0.05,**P<0.01。Note: Compared with the blank group, * P<0.05, ** P<0.01.
实验方法3:方法同实施例1,只是给药换为孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位。Experimental method 3: The method is the same as that in Example 1, except that the administration is replaced by alcohol extraction of the ethyl acetate extraction part of the composition of Fenugreek chrysanthemum.
实验结果:Experimental results:
对二甲苯所致小鼠耳廓肿胀的影响:结果见表12.结果表明孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(Ⅱ组)对二甲苯致小鼠耳廓肿胀有显著的抑制作用,与空白组比较有显著性差异(P<0.01)。Effect of p-xylene-induced auricle swelling in mice: the results are shown in Table 12. The results show that the alcohol-extracted ethyl acetate extraction part group (Group Ⅱ) of the Xylene-induced auricle swelling of the mice has a significant effect. Significant inhibitory effect, compared with the blank group, there was a significant difference (P<0.01).
表12:孝扇草羊耳菊组合物醇提各萃取部位对二甲苯致小鼠耳廓肿胀的影响(n=10)Table 12: The effect of the alcohol extraction of each extraction part of the composition of Filiaria sativa on the ear swelling of mice induced by xylene ( n=10)
注:与空白组比较,*P<0.01。Note: Compared with the blank group, * P<0.01.
实施例4:Example 4:
实验方法:experimental method:
动物分组:60只SD雄性大鼠,体重(160±10)g,适应饲养一周后,按每组10只随机分为6组:空白组、模型组、孝扇草羊耳菊组合物水提物低、中、高剂量组,阳性对照组。Animal grouping: 60 SD male rats, body weight (160±10) g, after a week of adaptation to feeding, they were randomly divided into 6 groups of 10 rats in each group: blank group, model group, and water extraction of chrysanthemum chrysanthemum composition Low, medium and high dose groups, positive control group.
造模及给药:阳性组、模型组、孝扇草羊耳菊组合物提取物低、中、高剂量组于大鼠右后足垫皮内注射0.1ml/只弗氏完全佐剂造模,空白组于于大鼠右后足垫皮内注射0.1ml/只生理盐水;造模同时分别按阳性组15mg·kg-1灌胃给予雷公藤多苷片,孝扇草羊耳菊组合物提取物低、中、高剂量组分别灌胃给予生药量2.5g·kg-1、5.0g·kg-1、10.0g·kg-1孝扇草羊耳菊组合物水提物,药物均调节至相应浓度按1ml·100g-1灌胃给药,模型组、空白组给予等体积的蒸馏水,每天一次,共28d。Modeling and administration: Positive group, model group, low-, medium-, and high-dose groups of the extracts of the composition of Fennelia sativa, medium, and high doses were injected intradermally with 0.1ml/rat's complete Freund's adjuvant into the right hind foot pad of the rats to establish the model , the blank group was intradermally injected with 0.1ml/rat normal saline on the right hind foot pad; while the model was being established, the positive group was given tripterygium glycosides tablets and fenugreek chrysanthemum composition by intragastric administration respectively at 15 mg·kg -1 The low-, medium-, and high-dose groups were administered intragastrically with 2.5 g·kg -1 , 5.0 g·kg -1 , and 10.0 g·kg -1 of the water extracts of the composition of the chrysanthemum chrysanthemum. To the corresponding concentration, 1ml·100g -1 was given by intragastric administration, and the model group and the blank group were given equal volume of distilled water, once a day, for 28 days in total.
检测指标:Detection Indicator:
①动物状态观察:包括毛色、光泽度及活动情况。① Observation of animal state: including coat color, gloss and activity.
②大鼠体重的影响:实验第ld称重,以后每7d称重1次。后一次的体重减去前一次的体重为各组大鼠体重增长数。② Effects on rat body weight: Weighed at the first ld of the experiment, and weighed once every 7 days thereafter. The body weight of the last time minus the body weight of the previous time is the weight gain of rats in each group.
③足爪肿胀度测量:造模前,大鼠双后肢拉直,在踝关节上0.5cm处用苦味酸做记号,然后放入足趾容积测量仪内,使足标记与水面相平,测量造模前各组大鼠的左、右足足容积(mL)5次,并记录,取其平均值作为造模前足肿胀度。并用同样方法测量造模后第6h、12h、24h、36h、48h、60h、72h、7d、11d右后足足趾容积,14d、18d、21d、24d、27d测量左、右后足足趾容积并记录。根据左、右后足趾容积与造模前容积计算足肿胀度。③Measurement of swelling degree of paws: before modeling, the rats’ hind limbs were straightened, marked with picric acid at 0.5 cm above the ankle joint, and then put into the toe volume measuring instrument, so that the paw marks were level with the water surface, and measured Before the modeling, the left and right paw volumes (mL) of the rats in each group were recorded 5 times, and the average value was taken as the swelling degree of the forefoot of the modeling. And use the same method to measure the volume of the right hind toe at 6h, 12h, 24h, 36h, 48h, 60h, 72h, 7d, and 11d after modeling, and measure the volume of the left and right hind toes at 14d, 18d, 21d, 24d, and 27d and record. The degree of foot swelling was calculated according to the volume of the left and right hind toes and the volume before modeling.
足肿胀度(mL)=造模后足趾容积-造模前足趾容积。Paw swelling degree (mL) = toe volume after modeling - toe volume before modeling.
④主要脏器指数测定:末次给药(第28d给药)4h后处死动物,取胸腺、脾脏,称重,计算脏器指数,脏器指数(mg·g-1)=(脏器重×1000)/体重。④Measurement of main organ index: Animals were sacrificed 4 hours after the last administration (administration on the 28th day), thymus and spleen were taken, weighed, and organ index was calculated, organ index (mg·g -1 )=(organ weight×1000 )/weight.
⑤滑膜组织病理切片:末次给药后处死动物,取膝关节滑膜,福尔马林固定,做常规HE病理切片检查。滑膜病理评分标准:炎细胞:0分,无;1分,稀疏、散在;2分,较密集;3分,大量。纤维组织增生:0分,无;1分,少量增生;2分,中等;3分,大量。滑膜组织增生:0,无;1分,单层;2分,2层;3分,3层。⑤Pathological section of synovial tissue: After the last administration, the animals were sacrificed, and the synovial membrane of the knee joint was taken, fixed in formalin, and routine HE pathological section examination was performed. Synovial pathological scoring criteria: inflammatory cells: 0 points, none; 1 point, sparse, scattered; 2 points, relatively dense; 3 points, a large number. Fibrous tissue hyperplasia: 0 points, no; 1 point, a small amount of hyperplasia; 2 points, moderate; 3 points, a large amount. Synovial hyperplasia: 0, no; 1 point, single layer; 2 points, 2 layers; 3 points, 3 layers.
实验结果:Experimental results:
①一般情况观察①Observation of general situation
造模后大鼠急性炎症反应明显,注射弗氏完全佐剂侧明显肿大。与空白组比较,造模大鼠活动减少,发生明显炎症反应时,进食明显减少,毛色欠光滑,踝关节肿大溃烂;给药组大鼠无溃烂现象;空白组大鼠与造模前无差异。After modeling, the acute inflammatory reaction of the rats was obvious, and the side injected with complete Freund's adjuvant was obviously swollen. Compared with the blank group, the activity of the model rats was reduced, and when obvious inflammatory reactions occurred, the food intake was significantly reduced, the coat color was not smooth, and the ankle joints were swollen and festered; the rats in the drug treatment group had no ulceration; difference.
②各组大鼠体重变化② Changes in body weight of rats in each group
造模28d内,模型组大鼠体重增长较正常组明显减少,差异具有显著性(P<0.05,P<0.01)。孝扇草羊耳菊组合物水提物各剂量组AA大鼠体重增加与模型组比较存在显著性差异(P<0.05,P<0.01),说明孝扇草羊耳菊组合物水提物各剂量组均能不同程度改善炎症对AA大鼠体重的影响。结果见表13。Within 28 days of modeling, the weight gain of the rats in the model group was significantly lower than that in the normal group, and the difference was significant (P<0.05, P<0.01). There was a significant difference (P<0.05, P<0.01) in the body weight gain of AA rats in each dose group of the water extract of the composition of F. syphilis and the model group (P<0.05, P<0.01), indicating that the water extract of the composition of F. All dose groups can improve the effect of inflammation on the body weight of AA rats to varying degrees. The results are shown in Table 13.
表13:各组大鼠体重变化情况(单位:g;n=10)Table 13: Changes in body weight of rats in each group (unit: g; n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
③大鼠关节肿胀度测量③Measurement of rat joint swelling
实验前所有大鼠足趾容积组间无显著性差异(P>0.05),实验周期内空白组大鼠四肢关节无红肿现象,行动灵活自如。造模后大鼠急性原发性炎症反应明显,足趾严重红肿,继发性炎症反应亦有发生,可见造模对侧足趾略红肿,但不及原发性炎症明显严重。造模28d,模型组大鼠大部分踝关节处发生不同程度的溃烂,阳性对照组及孝扇草羊耳菊组合物水提物治疗组均无溃烂现象。孝扇草羊耳菊组合物对大鼠足趾肿胀度原发性炎症及继发性炎症的影响见表14、15。Before the experiment, there was no significant difference in the toe volume of all the rats between the groups (P>0.05). During the experiment period, the rats in the blank group had no redness and swelling in the joints of the limbs, and they moved freely. After modeling, the acute primary inflammatory reaction of the rats was obvious, and the toes were severely red and swollen. Secondary inflammatory reactions also occurred. On the 28th day of modeling, most of the ankle joints of the rats in the model group were ulcerated to varying degrees, and there was no ulceration in the positive control group and the treatment group treated with the water extract of the chrysanthemum chrysanthemum composition. See Tables 14 and 15 for the effects of the composition of Filibulum chinensis on the primary inflammation and secondary inflammation of the toe swelling of rats.
表14:孝扇草羊耳菊组合物水提物对AA大鼠右侧足趾肿胀度的影响(n=10)Table 14: The effect of the water extract of the composition of filial scalloped chrysanthemum chrysanthemum on the swelling degree of the right foot of AA rats ( n=10)
(续)表14:孝扇草羊耳菊组合物水提物对AA大鼠右侧足趾肿胀度的影响(n=10)(Continued) Table 14: Effects of the water extract of the composition of Filiaria syphilis chrysanthemum on the swelling degree of the right toe of AA rats ( n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
表15:孝扇草羊耳菊组合物水提物对AA大鼠左侧足趾肿胀度的影响(n=10)Table 15: The effect of the water extract of the composition of filial scalloped chrysanthemum chrysanthemum on the degree of swelling of the left toe of AA rats ( n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
④主要脏器指数测定④ Determination of major organ indexes
结果见表16。结果表明孝扇草羊耳菊组合物水提物各剂量组均对AA大鼠胸腺、脾脏、肾上腺有明显的抑制作用。The results are shown in Table 16. The results showed that each dosage group of the water extract of the composition of F. filalis sylvestris chrysanthemum had obvious inhibitory effect on thymus, spleen and adrenal gland of AA rats.
表16:孝扇草羊耳菊组合物水提物对AA大鼠胸腺、脾、肾上腺重量的影响(n=10)Table 16: Effects of the water extract of the filial sage chrysanthemum composition water extract on the weight of the thymus, spleen and adrenal glands of AA rats ( n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
⑤滑膜病理⑤ Synovial pathology
正常大鼠滑膜组织未见明显的新生血管及炎症细胞浸润,滑膜细胞排列为1-2层。模型组有明显血管增生、滑膜细胞体积增大,滑膜增厚,炎性细胞浸润。治疗组滑膜组织可见少量新生血管及炎症细胞浸润,滑膜轻度增厚。模型组病理评分均显著高于正常组(P<0.01);孝扇草羊耳菊组合物低、中、高剂量组炎细胞、滑膜组织增生病理评分低于模型组(P<0.01)。结果见表17,附图1,2。No obvious neovascularization and inflammatory cell infiltration were found in the synovial tissue of normal rats, and the synovial cells were arranged in 1-2 layers. In the model group, there were obvious angiogenesis, synovial cell volume increase, synovial thickening, and inflammatory cell infiltration. In the synovial tissue of the treatment group, a small amount of new blood vessels and inflammatory cell infiltration were seen, and the synovial membrane was slightly thickened. The pathological scores of the model group were significantly higher than those of the normal group (P<0.01); the pathological scores of the inflammatory cells and synovial tissue hyperplasia in the low, medium and high dose groups of the composition group were lower than those of the model group (P<0.01). The results are shown in Table 17, accompanying drawings 1 and 2.
表17:孝扇草羊耳菊组合物水提物对AA大鼠滑膜病理评分的影响(n=10)Table 17: Effects of the aqueous extract of the filial genus Fructus chrysanthemum composition on the pathological score of the synovial membrane of AA rats ( n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
实施例5:Example 5:
实验方法:experimental method:
动物分组:60只SD雄性大鼠,体重(160±10)g,适应饲养一周后,按每组10只随机分为6组:空白组、模型组、孝扇草羊耳菊组合物醇提物低、中、高剂量组,阳性对照组。Animal grouping: 60 SD male rats, body weight (160±10) g, after one week of adaptation to feeding, were randomly divided into 6 groups of 10 rats in each group: blank group, model group, ethanol extraction of the composition of saffron chrysanthemum chrysanthemum Low, medium and high dose groups, positive control group.
造模及给药:同实施例4。Modeling and administration: the same as in Example 4.
检测指标:Detection Indicator:
①动物状态观察:同实施例4。①Observation of the state of the animal: the same as in Example 4.
②大鼠体重的影响:同实施例4。② Effect of rat body weight: same as in Example 4.
③足爪肿胀度测量:同实施例4。③Measurement of paw swelling: same as in Example 4.
④关节炎指数评分:大鼠造模后第14d开始,根据大鼠四肢关节炎症的红、肿及硬化程度定期记录临床炎症评分,以评价AA大鼠模型的继发性病变程度。大鼠单个肢体最高评分为4分,4肢总评分最高为16分。如下表18评分标准。④ Arthritis index score: From the 14th day after the rat model was established, the clinical inflammation score was regularly recorded according to the degree of redness, swelling and hardening of the joint inflammation of the rat limbs, so as to evaluate the degree of secondary lesions of the AA rat model. The highest score for a single limb of a rat is 4 points, and the highest score for all four limbs is 16 points. The following table 18 scoring criteria.
表18:关节炎指数评分表Table 18: Arthritis Index Score Form
⑤主要脏器指数测定:同实施例4。⑤ Determination of main organ index: same as Example 4.
实验结果:Experimental results:
①一般情况观察①Observation of general situation
造模后大鼠急性炎症反应明显,注射弗氏完全佐剂侧明显肿大。空白组大鼠在28d的试验周期内精神状态良好,毛发光泽,动作敏捷,饮食及饮水正常。与空白组比较,造模大鼠精神萎靡,发生明显炎症反应时,进食明显减少,毛色无光泽,体重增长慢,踝关节肿大溃烂;给药组大鼠基本无溃烂现象;空白组大鼠与造模前基本无差异。After modeling, the acute inflammatory reaction of the rats was obvious, and the side injected with Freund's complete adjuvant was obviously swollen. The rats in the blank group were in a good mental state during the 28-day test period, with shiny hair, quick movements, and normal diet and drinking water. Compared with the blank group, the model rats were listless, and when obvious inflammatory reactions occurred, the food intake was significantly reduced, the coat color was dull, the weight gain was slow, and the ankle joints were swollen and ulcerated; the rats in the drug treatment group basically had no ulceration; the rats in the blank group There is basically no difference from before modeling.
②各组大鼠体重变化② Changes in body weight of rats in each group
空白组大鼠在28d的试验周期内体重呈进行性增长。造模28d内,模型组大鼠体重增长量与空白组比较均有明显差异(P<0.01),孝扇草羊耳菊醇提物各剂量组AA大鼠体重增加与模型组比较存在显著性差异(P<0.01,P<0.05),说明孝扇草羊耳菊醇提物各剂量组均能不同程度改善炎症对AA大鼠体重的影响。结果见表19。The body weight of rats in the blank group increased progressively during the 28-day test period. Within 28 days of modeling, the weight gain of rats in the model group was significantly different from that in the blank group (P<0.01), and the weight gain of AA rats in each dose group of Alcohol Extract of Fructus Fructus Fructus was significantly different from that in the model group. The differences (P<0.01, P<0.05) indicated that each dosage group of Alcohol Extract of Fenugreek Fructus can improve the effect of inflammation on the body weight of AA rats to varying degrees. The results are shown in Table 19.
表19:各组大鼠体重变化情况(单位:g;n=10)Table 19: Changes in body weight of rats in each group (unit: g; n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
③大鼠关节肿胀度测量③Measurement of rat joint swelling
实验前所有大鼠足趾容积组间无显著性差异(P>0.05),实验周期内空白组大鼠四肢关节无红肿现象,行动灵活自如。造模后大鼠炎症明显,足趾严重红肿。造模后6h开始出现肿胀,继发性炎症反应亦有发生。孝扇草羊耳菊组合物醇提物各剂量组组对AA大鼠足趾原发性急性肿胀有不同程度的抑制作用。孝扇草羊耳菊组合物对大鼠足趾肿胀度原发性炎症及继发性炎症的影响见表20、21。Before the experiment, there was no significant difference in the toe volume of all the rats between the groups (P>0.05). During the experiment period, the rats in the blank group had no redness and swelling in the joints of the limbs, and they moved freely. After modeling, the rats had obvious inflammation, and the toes were severely red and swollen. Swelling began to appear 6 hours after modeling, and secondary inflammatory reactions also occurred. Each dose group of the alcohol extract of the composition of Filiaria sativa has different degrees of inhibitory effect on the primary acute swelling of the toes of AA rats. Table 20 and Table 21 show the effects of the composition of Filibulum chinensis on the primary inflammation and secondary inflammation of the toe swelling of rats.
表20:孝扇草羊耳菊组合物醇提物对AA大鼠右侧足趾肿胀度的影响(n=10)Table 20: The effect of the alcohol extract of the composition of filial piety fennel chrysanthemum chrysanthemum on the swelling degree of the right toe of AA rats ( n=10)
(续)表20:孝扇草羊耳菊组合物醇提物对AA大鼠右侧足趾肿胀度的影响(n=10)(Continued) Table 20: Effects of the alcohol extract of the composition of Fenugreek chrysanthemum on the swelling degree of the right toe of AA rats ( n=10)
(续)表20:孝扇草羊耳菊组合物醇提物对AA大鼠右侧足趾肿胀度的影响(n=10)(Continued) Table 20: Effects of the alcohol extract of the composition of Fenugreek chrysanthemum on the swelling degree of the right toe of AA rats ( n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
表21:孝扇草羊耳菊组合物醇提物对AA大鼠左侧足趾肿胀度的影响(n=10)Table 21: The effect of the alcohol extract of the composition of filial leaf grass Fructus chrysanthemum on the swelling degree of the left toe of AA rats ( n=10)
(续)表21:孝扇草羊耳菊组合物醇提物对AA大鼠左侧足趾肿胀度的影响(n=10)(Continued) Table 21: The effect of the alcohol extract of the composition of Fenugreek chrysanthemum on the swelling degree of the left toe of AA rats ( n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
④大鼠关节炎指数评分④ Rat Arthritis Index Score
实验结果见表22。结果表明所有造模组大鼠足趾、足垫、踝关节均出现了不同程度的红肿,到后期由于继发性肿胀的加剧,出现关节畸形及功能障碍的动物增多,模型组大鼠关节评分指数不断升高。孝扇草羊耳菊组合物醇提物各剂量组与模型组比较具有明显差异(P<0.01,P<0.05)。The experimental results are shown in Table 22. The results showed that the toes, foot pads, and ankle joints of all the rats in the model group had different degrees of redness and swelling. Due to the aggravation of secondary swelling in the later stage, the number of animals with joint deformities and dysfunction increased. The joint scores of rats in the model group The index keeps rising. Compared with the model group, there were significant differences (P<0.01, P<0.05).
表22:羊耳菊醇提取物对AA大鼠关节炎评分指数的影响(n=10)Table 22: Effect of Alcoholic Extract of Sheafflower on the Arthritis Score Index of AA Rats ( n=10)
注:与空白组比较,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
⑤主要脏器指数测定⑤ Determination of main organ index
结果见表23。结果表明孝扇草羊耳菊组合物醇提物各剂量组均对AA大鼠胸腺、脾脏、肾上腺有明显的抑制作用。The results are shown in Table 23. The results showed that each dose group of the alcohol extract of the composition of F. filariae Fructus chrysanthemum had obvious inhibitory effect on the thymus, spleen and adrenal gland of AA rats.
表23:孝扇草羊耳菊组合物醇提物对AA大鼠胸腺、脾、肾上腺重量的影响(n=10)Table 23: Effects of the alcoholic extract of the composition of filial leaf grass Fructus chrysanthemum on the weight of thymus, spleen and adrenal gland in AA rats ( n=10)
注:与空白组比较,#P<0.05,##P<0.01;与模型组比较,★P<0.05,★★P<0.01。Note: Compared with the blank group, # P<0.05, ## P<0.01; compared with the model group, ★ P<0.05, ★★ P<0.01.
实施例6:Embodiment 6:
实验方法:experimental method:
动物分组:60只SD雄性大鼠,体重(160±10)g,适应饲养一周后,按每组10只随机分为6组:空白组(I组)、模型组(II组)、阳性组(III组)、孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(IV组)、孝扇草羊耳菊组合物醇提正丁醇萃取部位组(V组)及各溶剂萃取后剩余部位组(VI组)。Animal grouping: 60 SD male rats, body weight (160±10) g, adapted to feeding for a week, were randomly divided into 6 groups according to 10 rats in each group: blank group (group I), model group (group II), positive group (Group III), Alcohol Extraction of Ethyl Acetate Extraction Parts Group (Group IV), Alcohol Extraction of Butanol Extraction Parts Group (Group V) and Each Solvent Extraction After the rest of the site group (VI group).
造模及给药:空白组(I组)、模型组(II组)、阳性组(III组)、孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(IV组)、孝扇草羊耳菊组合物醇提正丁醇萃取部位组(V组)及各溶剂萃取后剩余部位组(VI组)于大鼠右后足垫皮内注射0.1ml/只弗氏完全佐剂造模,空白组于于大鼠右后足垫皮内注射0.1ml/只生理盐水;造模同时分别按阳性组15mg·kg-1灌胃给予雷公藤多苷片,孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(IV组)、孝扇草羊耳菊组合物醇提正丁醇萃取部位组(V组)及各溶剂萃取后剩余部位组(VI组)分别灌胃给予10g·kg-1药液,药物均调节至相应浓度按1ml·100g-1灌胃给药,模型组、空白组给予等体积的蒸馏水,每天一次,共28d。Modeling and administration: blank group (group I), model group (group II), positive group (group III), alcohol extraction of ethyl acetate extraction part group (group IV), The composition of sheep ear chrysanthemum was extracted with alcohol and n-butanol extraction group (group V) and the remaining parts group after each solvent extraction (group VI) were intradermally injected with 0.1ml/piece of complete Freund's adjuvant in the right hind foot pad of rats. The rats in the blank group were intradermally injected with 0.1ml of normal saline on the right hind footpad; at the same time, the rats in the positive group were given tripterygium glycosides tablets and fenugreek chrysanthemum combination by intragastric administration at 15 mg·kg -1 Ethyl acetate extraction group (group IV), alcohol extraction group of n-butanol extraction group (group V) and the remaining parts group after each solvent extraction (group VI) were given by intragastric administration, respectively. 10g·kg -1 liquid medicine, all the drugs were adjusted to the corresponding concentration and administered by intragastric administration at 1ml·100g -1 , and the model group and blank group were given equal volume of distilled water once a day for a total of 28 days.
检测指标:Detection Indicator:
①动物状态观察:包括毛色、光泽度及活动情况。① Observation of animal state: including coat color, gloss and activity.
②大鼠体重的影响:实验第ld称重,以后每7d称重1次。后一次的体重减去前一次的体重为各组大鼠体重增长数。② Effects on rat body weight: Weighed at the first ld of the experiment, and weighed once every 7 days thereafter. The body weight of the last time minus the body weight of the previous time is the weight gain of rats in each group.
③足爪肿胀度测量:造模前,大鼠双后肢拉直,在踝关节上0.5cm处用苦味酸做记号,然后放入足趾容积测量仪内,使足标记与水面相平,测量造模前各组大鼠的左、右足足容积(mL)5次,并记录,取其平均值作为造模前足肿胀度。并用同样方法测量造模后第6h、18h、24h、48h、4d、8d、12d、16d、20d、24d、28d右后足足趾容积,12d、16d、20d、24d、28d测量左、右后足足趾容积并记录。根据左、右后足趾容积与造模前容积计算足肿胀度。③Measurement of swelling degree of paws: before modeling, the rats’ hind limbs were straightened, marked with picric acid at 0.5 cm above the ankle joint, and then put into the toe volume measuring instrument, so that the paw marks were level with the water surface, and measured Before the modeling, the left and right paw volumes (mL) of the rats in each group were recorded 5 times, and the average value was taken as the swelling degree of the forefoot of the modeling. And use the same method to measure the volume of the right hind foot at 6h, 18h, 24h, 48h, 4d, 8d, 12d, 16d, 20d, 24d, and 28d after modeling, and measure the volume of the left and right hind feet at 12d, 16d, 20d, 24d, and 28d. Full toe volume and record. The degree of foot swelling was calculated according to the volume of the left and right hind toes and the volume before modeling.
足肿胀度(mL)=造模后足趾容积-造模前足趾容积。Paw swelling degree (mL) = toe volume after modeling - toe volume before modeling.
④关节炎指数评分:大鼠造模后第14d开始,根据大鼠四肢关节炎症的红、肿及硬化程度定期记录临床炎症评分,以评价AA大鼠模型的继发性病变程度。大鼠单个肢体最高评分为4分,4肢总评分最高为16分。如前述表18评分标准。④ Arthritis index score: From the 14th day after the rat model was established, the clinical inflammation score was regularly recorded according to the degree of redness, swelling and hardening of the joint inflammation of the rat limbs, so as to evaluate the degree of secondary lesions of the AA rat model. The highest score for a single limb of a rat is 4 points, and the highest score for all four limbs is 16 points. Scoring criteria as in Table 18 above.
⑤主要脏器指数测定:末次给药4h后处死动物,取胸腺、脾脏,称重,计算脏器指数,脏器指数(mg·g-1)=(脏器重×1000)/体重。⑤ Determination of main organ index: Animals were sacrificed 4 hours after the last administration, thymus and spleen were taken out, weighed, and organ index was calculated, organ index (mg·g -1 )=(organ weight×1000)/body weight.
实验结果:Experimental results:
①一般情况观察①Observation of general situation
造模后大鼠急性炎症反应明显,注射弗氏完全佐剂侧明显肿大。空白组在28d的试验周期内精神状态良好,毛发光泽,动作敏捷,饮食及饮水正常。与空白组比较,造模大鼠活动较少,发生明显炎症反应时,进食明显减少,毛发无光泽,体重增长慢,踝关节肿大溃烂;给药组大鼠基本无溃烂现象;空白组大鼠与造模前基本无差异。After modeling, the acute inflammatory reaction of the rats was obvious, and the side injected with complete Freund's adjuvant was obviously swollen. The blank group was in a good mental state during the 28-day test period, with shiny hair, quick movements, and normal diet and drinking water. Compared with the blank group, the model rats were less active, and when obvious inflammatory reactions occurred, the food intake was significantly reduced, the hair was dull, the weight gain was slow, and the ankle joints were swollen and ulcerated; the rats in the drug treatment group basically had no ulceration; There was basically no difference between the mice and those before modeling.
②各组大鼠体重变化② Changes in body weight of rats in each group
造模28d内,模型组大鼠(II组)空白组(Ⅰ组)大鼠状态良好,毛发光泽,体重增加,动作自如,反应灵敏。造模28d后,造模组(Ⅱ组)大鼠体重增长量与空白组(Ⅰ组)比较有极显著性差异(P<0.01,P<0.05),造模后大鼠毛发枯槁,进食量减少,体重增长慢。造模14d,21d,27d孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(Ⅳ组)AA大鼠体重增加与模型组(Ⅱ组)比有极显著性差异(P<0.01)。造模21d和27d孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(Ⅳ组)大鼠体重增长量与模型组(Ⅱ组)比有极显著性差异(P<0.01),结果见表25。Within 28 days of modeling, the rats in the model group (Group II) and the rats in the blank group (Group I) were in good condition, with shiny hair, weight gain, free movement and sensitive response. After 28 days of modeling, the weight gain of rats in the modeling group (Group II) was significantly different from that in the blank group (Group I) (P<0.01, P<0.05). Decrease, slow weight gain. Modeling 14d, 21d, 27d The weight gain of AA rats in the Alcohol-extracted ethyl acetate extraction part group (Group Ⅳ) was significantly different from that in the model group (Group Ⅱ) (P<0.01) . There was a very significant difference (P<0.01) in the weight gain of the rats in the group (Group IV) compared with the model group (Group II) in the alcohol extraction of the ethyl acetate extraction part of the composition of the filial leaf grass and chrysanthemum chrysanthemum on the 21d and 27d of modeling. See Table 25.
表25:各组大鼠体重变化情况(n=10)Table 25: Changes in body weight of rats in each group ( n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
③大鼠关节肿胀度测量③Measurement of rat joint swelling
实验前所有的大鼠足趾容积组间无显著性差异(P>0.05),实验周期内空白组大鼠四肢关节无红肿现象,行动灵活自如。造模后大鼠急性原发性炎症明显,足趾严重红肿,造模后6h开始出现肿胀。模型组大鼠两侧足趾均出现肿胀、溃烂、水肿、关节畸形,耳朵红肿发炎,尾部出现结节状肿块等继发性病变,造模28d,造模大鼠踝关节处都出现不同程度的溃烂。孝扇草羊耳菊组合物醇提各萃取部位对AA大鼠右足足趾肿胀度影响实验结果见表17,孝扇草羊耳菊组合物醇提各萃取部位对AA大鼠左足足趾肿胀度影响实验结果见表26。Before the experiment, there was no significant difference in the toe volume of all the rats between the groups (P>0.05). During the experiment period, the rats in the blank group had no redness and swelling in the joints of the limbs, and they moved freely. After modeling, the acute primary inflammation of rats was obvious, and the toes were severely red and swollen, and swelling began to appear 6 hours after modeling. The rats in the model group had swelling, ulceration, edema, joint deformity on both sides of the toes, red, swollen and inflamed ears, and nodular lumps on the tail and other secondary lesions. After 28 days of modeling, the ankle joints of the modeling rats all appeared to varying degrees. fester. The experimental results of the effect of the alcohol extraction of each extraction part of the composition of Fenugreek chrysanthemum on the swelling degree of the right toe of AA rats are shown in Table 17. See Table 26 for the experimental results of degree influence.
表26:孝扇草羊耳菊组合物醇提各萃取部位对AA大鼠右足足趾肿胀度影响(n=10)Table 26: The effect of the alcohol extraction of each extraction part of the composition of filial leaf grass Fructus chrysanthemum on the swelling degree of the right toe of AA rats ( n=10)
(续)表26:孝扇草羊耳菊组合物醇提各萃取部位对AA大鼠右足足趾肿胀度影响(n=10)(Continued) Table 26: The effect of the alcohol extraction of the composition of Fenugreek chrysanthemum on the swelling degree of the right foot toes of AA rats ( n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
表27:孝扇草羊耳菊组合物醇提各萃取部位对AA大鼠左足足趾肿胀度影响(n=10)Table 27: The effect of the alcohol extraction of each extraction part of the composition of filial piety chrysanthemum chrysanthemum on the swelling degree of the left foot of AA rats ( n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
④大鼠关节炎指数评分④ Rat Arthritis Index Score
实验结果见表28,结果表明所有造模大鼠关节均出现不同程度的炎症,与空白组(Ⅰ组)对照均有极显著性差异(P<0.01)。阳性组(Ⅲ组)和孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(Ⅳ组)能明显改善关节炎症,降低AA大鼠关节炎指数,抑制继发性炎症,与模型组(Ⅱ组)比较均有极显著性差异(P<0.01)。The experimental results are shown in Table 28. The results showed that all the joints of the modeled rats had varying degrees of inflammation, and there were extremely significant differences (P<0.01) from those in the blank group (Group I). The positive group (Ⅲ group) and the alcohol-extracted ethyl acetate extraction part group (group Ⅳ) of Fenugreek chrysanthemum composition can significantly improve joint inflammation, reduce the arthritis index of AA rats, and inhibit secondary inflammation, compared with the model group ( Group Ⅱ) were significantly different (P<0.01).
表28:孝扇草羊耳菊组合物醇提各萃取部位对AA大鼠关节炎指数的影响(n=10)Table 28: The effect of alcohol extraction of each extraction part of the composition of filial leaf grass Fructus chrysanthemum on the arthritis index of AA rats ( n=10)
注:与空白组比*P<0.05,**P<0.01;与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01; compared with the model group ▲ P<0.05, ▲▲ P<0.01.
⑤主要脏器指数测定⑤ Determination of main organ index
实验结果见表29,结果表明模型组(Ⅱ组)AA大鼠胸腺出现萎缩,胸腺指数下降,脾脏指数升高,与空白对照组(Ⅰ组)相比均存在极显著差异(P<0.01,P<0.01),阳性组(Ⅲ组),孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(Ⅳ组)和正丁醇萃取部位组(V组)均能明显抑制胸腺的萎缩,升高大鼠胸腺指数,与模型组(Ⅱ组)比较存在极显著性差异(P<0.01,P<0.01,P<0.01)。阳性组(Ⅲ组)和孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组(Ⅳ组)均能明显升高脾脏指数,与模型组(Ⅱ组)比较存在显著性差异(P<0.01,P<0.05)。The experimental results are shown in Table 29. The results showed that the thymus of the AA rats in the model group (Group II) atrophied, the index of the thymus decreased, and the index of the spleen increased. Compared with the blank control group (Group I), there were extremely significant differences (P<0.01, P<0.01), the positive group (group III), the ethyl acetate extraction part group (group IV) and the n-butanol extraction part group (group V) of the fenugreek chrysanthemum composition can significantly inhibit the atrophy of the thymus, Increased thymus index in rats, compared with the model group (Group II), there was a very significant difference (P<0.01, P<0.01, P<0.01). Both the positive group (Ⅲ group) and the alcohol-extracted ethyl acetate extraction part group (group Ⅳ) can significantly increase the spleen index, and there is a significant difference compared with the model group (group Ⅱ) (P<0.01 , P<0.05).
表29孝扇草羊耳菊组合物醇提各萃取部位对AA大鼠脏器指数影响(x±s,n=10)Table 29 Effects of Alcoholic Extraction of Alcohol Extraction Parts on AA Rat Visceral Index of AA Rats (x±s, n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
实施案例7:Implementation case 7:
实验方法:experimental method:
动物分组:60只SD雄性大鼠,体重(160±10)g,适应饲养一周后,按每组10只随机分为6组:空白组、模型组、孝扇草醇提各萃取部位组(分别为石油醚萃取部位(Ⅰ组)、乙酸乙酯萃取部位(Ⅱ组)、正丁醇萃取部位(Ⅲ组)及各溶剂萃取后剩余部位(Ⅳ组))、阳性对照组,孝扇草提取物制备方法同实施例1,只是去除了组合物中的羊耳菊组分。Animal grouping: 60 SD male rats with a body weight of (160±10) g, after being fed for one week, they were randomly divided into 6 groups of 10 rats in each group: blank group, model group, and each extraction part group of Alcohol Extraction ( Respectively, petroleum ether extraction parts (group Ⅰ), ethyl acetate extraction parts (group Ⅱ), n-butanol extraction parts (group Ⅲ) and the remaining parts after each solvent extraction (group Ⅳ), the positive control group, and the The preparation method of the extract is the same as that in Example 1, except that the fescue component in the composition is removed.
造模及给药:阳性组、模型组、孝扇草醇提各萃取部位组(分别为石油醚萃取部位(Ⅰ组)、乙酸乙酯萃取部位(Ⅱ组)、正丁醇萃取部位(Ⅲ组)及各溶剂萃取后剩余部位(Ⅳ组))、阳性对照组于大鼠右后足垫皮内注射0.1ml/只弗氏完全佐剂造模,空白组于大鼠右后足垫皮内注射0.1ml/只生理盐水;造模同时分别按阳性组15mg·kg-1灌胃给予雷公藤多苷片,孝扇草醇提各萃取部位组(分别为石油醚萃取部位(Ⅰ组)、乙酸乙酯萃取部位(Ⅱ组)、正丁醇萃取部位(Ⅲ组)及各溶剂萃取后剩余部位(Ⅳ组))分别灌胃给予生药量10.0g·kg-1药物,药物均调节至相应浓度按1ml·100g-1灌胃给药,模型组、空白组给予等体积的蒸馏水,每天一次,共28d。Modeling and drug administration: positive group, model group, each extraction part group of Alcohol Extraction (respectively, petroleum ether extraction part (Group Ⅰ), ethyl acetate extraction part (Group Ⅱ), n-butanol extraction part (Group Ⅲ) group) and the remaining parts after each solvent extraction (Group IV)), the positive control group was intradermally injected with 0.1ml/piece Freund's complete adjuvant into the right hind foot pad of rats to establish a model, and the blank group was injected into the skin of the right hind foot pad of rats. 0.1ml/saline was injected internally; at the same time as the model was established, Tripterygium wilfordii Polyglycoside Tablets were given intragastrically at 15 mg·kg -1 in the positive group, and each extraction site group (respectively, petroleum ether extraction sites (group Ⅰ) , ethyl acetate extraction site (group Ⅱ), n-butanol extraction site (group Ⅲ) and the remaining site after each solvent extraction (group Ⅳ)) were given 10.0 g·kg -1 crude drug by intragastric administration, and the drug was adjusted to The corresponding concentration was given by intragastric administration of 1ml·100g -1 , and the model group and the blank group were given equal volumes of distilled water once a day for 28 days in total.
检测指标:Detection Indicator:
①动物状态观察:包括毛色、光泽度及活动情况。① Observation of animal state: including coat color, gloss and activity.
②大鼠体重的影响:实验第ld称重,以后每7d称重1次。后一次的体重减去前一次的体重为各组大鼠体重增长数。② Effects on rat body weight: Weighed at the first ld of the experiment, and weighed once every 7 days thereafter. The body weight of the last time minus the body weight of the previous time is the weight gain of rats in each group.
③足爪肿胀度测量:造模前,大鼠双后肢拉直,在踝关节上0.5cm处用苦味酸做记号,然后放入足趾容积测量仪内,使足标记与水面相平,测量造模前各组大鼠的左、右足足容积(mL)5次,并记录,取其平均值作为造模前足肿胀度。并用同样方法测量造模后第6h、12h、24h、36h、48h、60h、72h、7d、11d右后足足趾容积,14d、18d、21d、24d、27d测量左、右后足足趾容积并记录。根据左、右后足趾容积与造模前容积计算足肿胀度。③Measurement of swelling degree of paws: before modeling, the rats’ hind limbs were straightened, marked with picric acid at 0.5 cm above the ankle joint, and then put into the toe volume measuring instrument, so that the paw marks were level with the water surface, and measured Before the modeling, the left and right paw volumes (mL) of the rats in each group were recorded 5 times, and the average value was taken as the swelling degree of the forefoot of the modeling. And use the same method to measure the volume of the right hind toe at 6h, 12h, 24h, 36h, 48h, 60h, 72h, 7d, and 11d after modeling, and measure the volume of the left and right hind toes at 14d, 18d, 21d, 24d, and 27d and record. The degree of foot swelling was calculated according to the volume of the left and right hind toes and the volume before modeling.
足肿胀度(mL)=造模后足趾容积-造模前足趾容积。Paw swelling degree (mL) = toe volume after modeling - toe volume before modeling.
④关节炎指数评分:大鼠造模后第14d开始,根据大鼠四肢关节炎症的红、肿及硬化程度定期记录临床炎症评分,以评价AA大鼠模型的继发性病变程度。大鼠单个肢体最高评分为4分,4肢总评分最高为16分。如前述表18评分标准。④ Arthritis index score: From the 14th day after the rat model was established, the clinical inflammation score was regularly recorded according to the degree of redness, swelling and hardening of the joint inflammation of the rat limbs, so as to evaluate the degree of secondary lesions of the AA rat model. The highest score for a single limb of a rat is 4 points, and the highest score for all four limbs is 16 points. Scoring criteria as in Table 18 above.
⑤主要脏器指数测定:末次给药4h后处死动物,取胸腺、脾脏,称重,计算脏器指数,脏器指数(mg·g-1)=(脏器重×1000)/体重。⑤ Determination of main organ index: Animals were sacrificed 4 hours after the last administration, thymus and spleen were taken out, weighed, and organ index was calculated, organ index (mg·g -1 )=(organ weight×1000)/body weight.
实验结果:Experimental results:
①一般情况观察①Observation of general situation
造模后大鼠急性炎症反应明显,注射弗氏完全佐剂侧明显肿大。空白组大鼠在28d的试验周期内精神状态良好,毛发光泽,动作敏捷,饮食及饮水正常,体重呈进行性增长。与空白组比较,造模大鼠精神萎靡,发生明显炎症反应时,即造模后第18-24d,进食明显减少,毛色无光泽,体重增长慢,踝关节肿大溃烂;给药组大鼠基本无溃烂现象;空白组大鼠与造模前基本无差异。After modeling, the acute inflammatory reaction of the rats was obvious, and the side injected with complete Freund's adjuvant was obviously swollen. The rats in the blank group were in a good mental state during the 28-day test period, with shiny hair, quick movements, normal diet and drinking water, and a progressive increase in body weight. Compared with the blank group, the model rats were depressed, and when obvious inflammatory reactions occurred, that is, on the 18th to 24th day after modeling, the food intake was significantly reduced, the hair color was dull, the weight growth was slow, and the ankle joints were swollen and festered; the rats in the drug treatment group There was basically no ulceration; the rats in the blank group were basically the same as those before modeling.
②各组大鼠体重变化② Changes in body weight of rats in each group
造模28d内,模型组大鼠体重增长量与空白组比较均有明显差异(P<0.01,P<0.05),孝扇草醇提各萃取部位组AA大鼠体重增加与模型组比较存在显著性差异(P<0.01,P<0.05),说明孝扇草醇提各萃取部位组均能不同程度改善炎症对AA大鼠体重的影响。结果见表30。Within 28 days of modeling, the weight gain of rats in the model group was significantly different from that in the blank group (P<0.01, P<0.05). There were significant differences (P<0.01, P<0.05), which indicated that the alcohol extraction of Filiaria miltiorrhiza could improve the effect of inflammation on the body weight of AA rats to varying degrees. The results are shown in Table 30.
整个实验过程中,空白组(Ⅰ组)大鼠状态良好,毛发光泽,体重增加,动作自如,反应灵敏。造模28d后,所有造模组(Ⅱ组)大鼠体重增长量与空白组(Ⅰ组)比均有极显著性差异(P<0.01),造模后大鼠毛发枯槁,进食量减少,体重增长慢,造模14d,体重略有增加,同时结果表明,造模14d孝扇草醇提乙酸乙酯萃取部位组(Ⅳ组)AA大鼠体重增加与模型组(Ⅱ组)比有显著性差异(P<0.05)。造模20d和28d孝扇草醇提乙酸乙酯萃取部位组(Ⅳ组)大鼠体重增长量与模型组(Ⅱ组)比有极显著性差异(P<0.01,P<0.01)。与孝扇草羊耳菊组合物醇提各萃取部位组相比,单用孝扇草醇提各萃取部位的AA大鼠体重增长较缓慢,增长量较小,状态较低迷,进食欲望低,反应略迟钝。结果见表30。During the whole experiment, the rats in the blank group (group I) were in good condition, with shiny hair, weight gain, free movement and sensitive response. After 28 days of modeling, the weight gain of rats in all modeling groups (group II) was significantly different from that in the blank group (group I) (P<0.01). The body weight increased slowly, and the body weight increased slightly on the 14th day of modeling. At the same time, the results showed that the weight gain of AA rats in the group (Group IV) was significantly higher than that in the model group (Group II). Sex difference (P<0.05). There was a very significant difference (P<0.01, P<0.01) in the weight gain of the rats in the 20d and 28d model-making days compared with the model group (Group Ⅱ) in the rats of the ethyl acetate extraction part group (Group Ⅳ). Compared with the group of extract parts extracted by alcohol extraction of F. miltiorrhiza, AA rats whose extract parts were extracted by alcohol alone had a slower weight gain, a smaller increase, a lower state of depression, and a lower desire to eat. Slightly sluggish in response. The results are shown in Table 30.
表30孝扇草醇提各萃取部位对AA大鼠体重增长的影响(n=10)Table 30 The effect of each extraction part of Alcohol Extraction on AA Rat Body Weight Gain ( n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
②孝扇草醇提各萃取部位对AA大鼠足趾肿胀度的影响②Effects of various extraction parts of Alcohol Extraction of Filiaria miltiorrhiza on the degree of swelling of the toes of AA rats
造模后大鼠急性原发性炎症明显,足趾严重红肿,造模后6h开始出现肿胀。造模8d原发性病变达到高峰期。造模12d开始出现继发性病变,16~20d左足足趾肿胀度达到高峰值,两侧足趾均出现肿胀、溃烂、水肿、关节畸形,耳朵红肿发炎,尾部出现结节状肿块等继发性病变,造模28d,造模大鼠踝关节处都出现不同程度的溃烂。与孝扇草羊耳菊组合物醇提各萃取不为相比,单用孝扇草醇提各萃取部位的AA大鼠右足足趾肿胀度较严重,疗效缓慢,效果平和,继发性肿胀度亦较严重。After modeling, the acute primary inflammation of rats was obvious, and the toes were severely red and swollen, and swelling began to appear 6 hours after modeling. The primary lesion reached its peak on the 8th day after modeling. Secondary lesions began to appear on the 12th day of modeling, and the swelling degree of the left toe reached a peak on the 16th to 20th day. Swelling, ulceration, edema, and joint deformity appeared in the toes on both sides, red, swollen and inflamed ears, and nodular mass in the tail. On the 28th day of modeling, the ankle joints of the modeling rats all had varying degrees of ulceration. Compared with the different extractions of the Alcohol-extracted Alcohol-extracted Alcohol-extracted AA Rats, the swelling of the right toe of AA rats was more serious, the curative effect was slow, the effect was mild, and the secondary swelling degree is also more serious.
孝扇草醇提各萃取部位对AA大鼠左足足趾肿胀度影响实验结果见表31。Table 31 shows the experimental results of the effect of the various extraction parts of the Alcohol Extraction on the swelling degree of the left toes of AA rats.
表31孝扇草醇提各萃取部位对AA大鼠右足足趾肿胀度影响(n=10)Table 31 The effect of each extraction part on the swelling degree of the right foot of the AA rat by the alcohol extraction of fennel grass ( n=10)
表31孝扇草醇提各萃取部位对AA大鼠右足足趾肿胀度影响(n=10)Table 31 The effect of each extraction part on the swelling degree of the right foot of the AA rat by the alcohol extraction of fennel grass ( n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
表31孝扇草醇提各萃取部位对AA大鼠左足足趾肿胀度影响(n=10)Table 31 The effect of each extraction part on the swelling degree of the left foot of AA rats by alcohol extraction n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
③孝扇草醇提各萃取部位对AA大鼠关节炎指数的影响③Effects of different extraction parts of Alcohol Extraction of Filiaria miltiorrhiza on the arthritis index of AA rats
实验结果见表45,结果表明所有造模大鼠关节均出现不同程度的炎症,与空白组(Ⅰ组)对照均有极显著性差异(P<0.01)。阳性组(Ⅲ组)和孝扇草醇提乙酸乙酯萃取部位组(Ⅳ组)能明显改善关节炎症,降低AA大鼠关节炎指数,抑制继发性炎症,与模型组(Ⅱ组)比较均有极显著性差异(P<0.01,P<0.01)。与孝扇草羊耳菊组合物醇提各萃取部位相比,单用孝扇草醇提各萃取部位的AA大鼠关节炎指数普遍较高,关节炎症明显。The experimental results are shown in Table 45. The results showed that all the joints of the modeled rats had varying degrees of inflammation, and there were extremely significant differences (P<0.01) from those in the blank group (Group I). The positive group (Ⅲ group) and the ethyl acetate extraction part group (group Ⅳ) can significantly improve the joint inflammation, reduce the arthritis index of AA rats, and inhibit the secondary inflammation, compared with the model group (group Ⅱ). There are extremely significant differences (P<0.01, P<0.01). Compared with the alcohol-extracted parts of S. chinensis chrysanthemum, AA rats with alcohol-extracted parts of S. syphilis alone generally have higher arthritis index and obvious joint inflammation.
表45孝扇草醇提各萃取部位对AA大鼠关节炎指数的影响(n=10)Table 45 The influence of each extraction part of Alcohol Extraction on AA Rat Arthritis Index ( n=10)
注:与空白组比*P<0.05,**P<0.01;与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01; compared with the model group ▲ P<0.05, ▲▲ P<0.01.
④孝扇草醇提各萃取部位对AA大鼠脏器指数的影响④Effects of different extracting parts of Alcohol Extraction of Filiaria miltiorrhiza on the visceral index of AA rats
实验结果见表46,结果表明模型组(Ⅱ组)AA大鼠胸腺出现萎缩,胸腺指数下降,脾脏指数升高,与空白对照组(Ⅰ组)相比均存在极显著差异(P<0.01,P<0.01),阳性组(Ⅲ组)和孝扇草醇提乙酸乙酯萃取部位组(Ⅳ组)均能明显抑制胸腺的萎缩,升高大鼠胸腺指数,与模型组(Ⅱ组)比较存在极显著性差异(P<0.01,P<0.01)。与孝扇草羊耳菊组合物醇提各萃取部位相比,单用孝扇草醇提各萃取部位的AA大鼠胸腺萎缩较严重,脾脏指数较高,疗效平和。The experimental results are shown in Table 46. The results showed that the thymus of the AA rats in the model group (Group II) atrophied, the index of the thymus decreased, and the index of the spleen increased. Compared with the blank control group (Group I), there were extremely significant differences (P<0.01, P<0.01), the positive group (Ⅲ group) and the ethyl acetate extraction part group (group Ⅳ) can significantly inhibit the atrophy of the thymus and increase the thymus index of rats, compared with the model group (group Ⅱ) there is a significant Significant difference (P<0.01, P<0.01). Compared with the alcohol-extracted parts of AA rats with Alcohol-extracted extract parts of F. syphilis, the thymus atrophy of AA rats was more severe, the spleen index was higher, and the curative effect was mild.
表46孝扇草醇提各萃取部位对AA大鼠脏器指数影响(n=10)Table 46 The effect of each extraction part on the viscera index of AA rats by alcohol extraction n=10)
注:与空白组比*P<0.05,**P<0.01,与模型组比▲P<0.05,▲▲P<0.01。Note: Compared with the blank group * P<0.05, ** P<0.01, compared with the model group ▲ P<0.05, ▲▲ P<0.01.
实施例8:Embodiment 8:
实验方法:experimental method:
比较孝扇草羊耳菊组合物水提物、醇提物及醇提乙酸乙酯萃取部位对AA大鼠右侧及左侧足趾肿胀度的影响。△足趾肿胀度(ml)=第27d足趾肿胀度-第1d足趾肿胀度。To compare the effects of water extract, alcohol extract and ethyl acetate extraction part of the composition of Filiaria fragrans Fructus chrysanthemum on the swelling degree of right and left toes of AA rats. △Toe swelling degree (ml) = toe swelling degree on the 27th day - toe swelling degree on the 1st day.
实验结果见表47,结果表明模孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位组右侧及左侧足肿胀度均较水提物组及醇提物组小,且具有显著性差异(P<0.01,P<0.05)。说明孝扇草羊耳菊组合物醇提乙酸乙酯萃取部位疗效最佳。The experimental results are shown in Table 47. The results show that the swelling degree of the right and left paws of the Ethyl Acetate Extraction Group with the alcohol extraction group is smaller than that of the Water Extraction Group and the Alcohol Extraction Group, and there is a significant difference. Difference (P<0.01, P<0.05). It shows that the alcohol-extracted ethyl acetate extract part of the composition of filial scalloped chrysanthemum has the best curative effect.
表47孝扇草羊耳菊组合物不同提取物对AA大鼠右侧足趾肿胀度的影响(n=10)Table 47 The effect of different extracts of the filial piety scalloped chrysanthemum composition on the swelling degree of the right toe of AA rats ( n=10)
注:与水提物组比**P<0.01,与醇提物组比▲P<0.05。Note: ** P<0.01 compared with the water extract group, ▲ P<0.05 compared with the alcohol extract group.
表48孝扇草羊耳菊组合物不同提取物对AA大鼠左侧足趾肿胀度的影响(n=10)Table 48 The effect of different extracts of the filial piety scalloped chrysanthemum composition on the swelling degree of the left foot of the AA rat ( n=10)
注:与水提物组比*P<0.05,与醇提物组比▲P<0.05。Note: * P<0.05 compared with water extract group, ▲ P<0.05 compared with alcohol extract group.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610183884.8A CN105796630B (en) | 2016-03-28 | 2016-03-28 | A kind of filial fan grass composition and its application |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610183884.8A CN105796630B (en) | 2016-03-28 | 2016-03-28 | A kind of filial fan grass composition and its application |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105796630A CN105796630A (en) | 2016-07-27 |
CN105796630B true CN105796630B (en) | 2019-12-24 |
Family
ID=56453999
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610183884.8A Active CN105796630B (en) | 2016-03-28 | 2016-03-28 | A kind of filial fan grass composition and its application |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105796630B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101934016A (en) * | 2010-08-31 | 2011-01-05 | 胡枝清 | External medicament and mineral-containing plaster for treating arthritis |
CN101991811A (en) * | 2009-08-26 | 2011-03-30 | 广西玉林制药有限责任公司 | Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof |
CN102000203A (en) * | 2010-12-04 | 2011-04-06 | 江敏 | A traditional Chinese medicine for dispelling wind and eliminating dampness, promoting blood circulation and removing blood stasis |
-
2016
- 2016-03-28 CN CN201610183884.8A patent/CN105796630B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101991811A (en) * | 2009-08-26 | 2011-03-30 | 广西玉林制药有限责任公司 | Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof |
CN101934016A (en) * | 2010-08-31 | 2011-01-05 | 胡枝清 | External medicament and mineral-containing plaster for treating arthritis |
CN102000203A (en) * | 2010-12-04 | 2011-04-06 | 江敏 | A traditional Chinese medicine for dispelling wind and eliminating dampness, promoting blood circulation and removing blood stasis |
Also Published As
Publication number | Publication date |
---|---|
CN105796630A (en) | 2016-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104367765A (en) | Traditional Chinese medicinal composition for treating depression as well as preparation method and application thereof | |
CN103041173A (en) | Traditional Chinese medicine external preparation for curing dermatitis and eczema and preparing method thereof | |
CN103690620B (en) | A kind of external application Chinese medicine compound for the treatment of rheumatoid arthritis and preparation method thereof | |
CN105169017A (en) | Traditional Chinese medicine for treating kidney stone and preparation method of traditional Chinese medicine | |
CN104306498B (en) | Traditional Chinese medicine composition for treating kidney deficiency cold-damp type leucorrhea of women and preparation method thereof | |
CN102579559B (en) | Bauhinia championii ethyl acetate extract, n-butyl alcohol extract, and preparation methods and applications thereof | |
CN101912527A (en) | Medicinal preparation for curing wind chill blockage disease and preparation method thereof | |
CN101991811B (en) | Traditional Chinese medicine composition for treating rheumatism arthralgia, cold headache, abdominal cavity pain and chilblain and preparation method thereof | |
CN105796630B (en) | A kind of filial fan grass composition and its application | |
CN101391013B (en) | Traditional Chinese medicine composition for treating skin disease and preparation method thereof | |
CN101439069A (en) | Leaf extract of Herba siegesbeckiae, preparation method and uses thereof | |
CN102579558B (en) | Application of bauhinia championii total flavonoids in preparation of medicine for treating rheumatoid arthritis | |
CN104225386B (en) | A kind of compound thunder god vine gel cream of high-efficiency low-toxicity and preparation method thereof | |
CN101337026A (en) | External medicine composition for treating gout | |
CN101564453A (en) | Medicine for treating chronic nonspecific ulcerative colitis and preparation method thereof | |
CN106511394B (en) | Uses of Jiuxiang Insect Fatty Oil Extract | |
CN101167798B (en) | Preparation method and application of Huangqin decoction for treating ulcerative colitis active part | |
CN105194352B (en) | A kind of Chinese medicine composition and preparation method thereof improving learning and memory | |
CN116036225B (en) | A naturally derived external pharmaceutical composition for treating arthritis | |
CN116549522B (en) | Application of traditional Chinese medicine composition in gout | |
CN103110700A (en) | Fraxinus mandshurica extract for treating rheumatoid arthritis | |
CN101926859B (en) | Chinese medicinal composition | |
CN102218103B (en) | Application of extractive of adinandra nitida leaves in preparation of anti-inflammatory analgesia medicament | |
CN102688254B (en) | Medicinal composition for treating chronic diarrhea and preparation method and use thereof | |
CN1177592C (en) | Application of Radix Radix Radix Radix Extract Total Saponins in the Preparation of Drugs for Treating Myocarditis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Huang Zhen Inventor after: Zhong Xiaoming Inventor after: Chen Mengjing Inventor before: Chen Mengjing Inventor before: Huang Zhen Inventor before: Zhong Xiaoming |
|
GR01 | Patent grant | ||
GR01 | Patent grant |